(4S)-N-(TERT-BUTYLDIMETHYLSILYL)AZETIDIN-2-ONE-4-CARBOXYLIC ACID, 500mg

N-Acetyl-L-histidine Monohydrate>99.0%(HPLC)(T)25g

(4-Methoxy-3-(trifluoromethyl)phenyl)boronic acid, 95.0%, 250mg

N-Methyl-4-bromo-3-methylbenzamide, 98%, 1g

5-Nitropicolinonitrile, 95.0%, 50g

(S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-bromophenyl)propanoic acid, 98%, 5g

tert-Butyl 4-hydroxy-4-(hydroxymethyl)piperidine-1-carboxylate, 95.0%, 1g

2-(2,6-Dichlorobenzoyl)-5-(1,3-dioxolan-2-yl)thiophene, 97.0%, 1g

2-Methyloxetan-3-one, 97%, 100mg

Vinyltriethoxysilane, = 98% (GC), 100g

(R)-3-Methylpyrrolidin-2-one, 98+%, 1g

5,5',5'',5'''-(Ethene-1,1,2,2-tetrayl)tetrakis(2-hydroxybenzaldehyde), 97%, 1g

[(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)methyl]amine hydrochloride, 95.0%, 1g